The Effect of Community Pharmacy Technicians on Industry Standard Adherence Performance Measures after Cognitive Pharmaceutical Services Training

Leanne Justis, Jeremy Crain, Merrill L. Marchetti, Kenneth Hohmeier

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Cognitive pharmaceutical services (CPS) provided by pharmacists can improve patient adherence and industry standard performance measures. Community pharmacy technicians can aid in CPS support tasks on training, but it is unknown to what extent. Objective: To determine the effect of community pharmacy technicians on industry standard adherence performance measures after CPS training. Methods: Sixteen community pharmacy technicians within a supermarket chain division were chosen to participate in CPS training based on internal pharmacy benchmarking data. The training program consisted of 3 components: (1) classroom and (2) web-based training for medication therapy management platforms and (3) Hands-on in-pharmacy training. Researchers used pharmacy-specific EQuIPP reports of the proportion of days covered (PDC) for adherence related to diabetes, cholesterol, and hypertension to measure the primary outcome. September through October 2015 represented baseline data. November 2015 through March 2016 represented intervention data. Descriptive and inferential statistics were utilized for this retrospective analysis. The University of Tennessee Institutional Review Board classified the study exempt from review. Results: Overall, 100% of Cholesterol PDC 4-Star sites improved to a 5-Star score and 56% of sites improved in the Diabetes PDC score. All sites maintained a 5-Star score for RASA PDC postintervention. An average increase of 2.36% was observed for Cholesterol PDC across all sites. Possible lag time between the intervention and score improvements may limit relatability of results. Conclusions: This is the first study to report a positive trend between technician involvement in CPS and improvement in industry standard adherence performance measures. Further research capturing a longer time frame may be beneficial.

Original languageEnglish (US)
Pages (from-to)230-233
Number of pages4
JournalJournal of Pharmacy Technology
Volume32
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Pharmaceutical Services
Pharmacies
Industry
Cholesterol
Medication Therapy Management
Benchmarking
Research Ethics Committees
Patient Compliance
Pharmacists
Research Personnel
Outcome Assessment (Health Care)
Pharmacy Technicians
Hypertension
Education
Research

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

The Effect of Community Pharmacy Technicians on Industry Standard Adherence Performance Measures after Cognitive Pharmaceutical Services Training. / Justis, Leanne; Crain, Jeremy; Marchetti, Merrill L.; Hohmeier, Kenneth.

In: Journal of Pharmacy Technology, Vol. 32, No. 6, 01.12.2016, p. 230-233.

Research output: Contribution to journalArticle

@article{e38e09ece754485eb1a386796ec148a0,
title = "The Effect of Community Pharmacy Technicians on Industry Standard Adherence Performance Measures after Cognitive Pharmaceutical Services Training",
abstract = "Background: Cognitive pharmaceutical services (CPS) provided by pharmacists can improve patient adherence and industry standard performance measures. Community pharmacy technicians can aid in CPS support tasks on training, but it is unknown to what extent. Objective: To determine the effect of community pharmacy technicians on industry standard adherence performance measures after CPS training. Methods: Sixteen community pharmacy technicians within a supermarket chain division were chosen to participate in CPS training based on internal pharmacy benchmarking data. The training program consisted of 3 components: (1) classroom and (2) web-based training for medication therapy management platforms and (3) Hands-on in-pharmacy training. Researchers used pharmacy-specific EQuIPP reports of the proportion of days covered (PDC) for adherence related to diabetes, cholesterol, and hypertension to measure the primary outcome. September through October 2015 represented baseline data. November 2015 through March 2016 represented intervention data. Descriptive and inferential statistics were utilized for this retrospective analysis. The University of Tennessee Institutional Review Board classified the study exempt from review. Results: Overall, 100{\%} of Cholesterol PDC 4-Star sites improved to a 5-Star score and 56{\%} of sites improved in the Diabetes PDC score. All sites maintained a 5-Star score for RASA PDC postintervention. An average increase of 2.36{\%} was observed for Cholesterol PDC across all sites. Possible lag time between the intervention and score improvements may limit relatability of results. Conclusions: This is the first study to report a positive trend between technician involvement in CPS and improvement in industry standard adherence performance measures. Further research capturing a longer time frame may be beneficial.",
author = "Leanne Justis and Jeremy Crain and Marchetti, {Merrill L.} and Kenneth Hohmeier",
year = "2016",
month = "12",
day = "1",
doi = "10.1177/8755122516669379",
language = "English (US)",
volume = "32",
pages = "230--233",
journal = "Journal of Pharmacy Technology",
issn = "8755-1225",
publisher = "Harvey Whitney Books Company",
number = "6",

}

TY - JOUR

T1 - The Effect of Community Pharmacy Technicians on Industry Standard Adherence Performance Measures after Cognitive Pharmaceutical Services Training

AU - Justis, Leanne

AU - Crain, Jeremy

AU - Marchetti, Merrill L.

AU - Hohmeier, Kenneth

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background: Cognitive pharmaceutical services (CPS) provided by pharmacists can improve patient adherence and industry standard performance measures. Community pharmacy technicians can aid in CPS support tasks on training, but it is unknown to what extent. Objective: To determine the effect of community pharmacy technicians on industry standard adherence performance measures after CPS training. Methods: Sixteen community pharmacy technicians within a supermarket chain division were chosen to participate in CPS training based on internal pharmacy benchmarking data. The training program consisted of 3 components: (1) classroom and (2) web-based training for medication therapy management platforms and (3) Hands-on in-pharmacy training. Researchers used pharmacy-specific EQuIPP reports of the proportion of days covered (PDC) for adherence related to diabetes, cholesterol, and hypertension to measure the primary outcome. September through October 2015 represented baseline data. November 2015 through March 2016 represented intervention data. Descriptive and inferential statistics were utilized for this retrospective analysis. The University of Tennessee Institutional Review Board classified the study exempt from review. Results: Overall, 100% of Cholesterol PDC 4-Star sites improved to a 5-Star score and 56% of sites improved in the Diabetes PDC score. All sites maintained a 5-Star score for RASA PDC postintervention. An average increase of 2.36% was observed for Cholesterol PDC across all sites. Possible lag time between the intervention and score improvements may limit relatability of results. Conclusions: This is the first study to report a positive trend between technician involvement in CPS and improvement in industry standard adherence performance measures. Further research capturing a longer time frame may be beneficial.

AB - Background: Cognitive pharmaceutical services (CPS) provided by pharmacists can improve patient adherence and industry standard performance measures. Community pharmacy technicians can aid in CPS support tasks on training, but it is unknown to what extent. Objective: To determine the effect of community pharmacy technicians on industry standard adherence performance measures after CPS training. Methods: Sixteen community pharmacy technicians within a supermarket chain division were chosen to participate in CPS training based on internal pharmacy benchmarking data. The training program consisted of 3 components: (1) classroom and (2) web-based training for medication therapy management platforms and (3) Hands-on in-pharmacy training. Researchers used pharmacy-specific EQuIPP reports of the proportion of days covered (PDC) for adherence related to diabetes, cholesterol, and hypertension to measure the primary outcome. September through October 2015 represented baseline data. November 2015 through March 2016 represented intervention data. Descriptive and inferential statistics were utilized for this retrospective analysis. The University of Tennessee Institutional Review Board classified the study exempt from review. Results: Overall, 100% of Cholesterol PDC 4-Star sites improved to a 5-Star score and 56% of sites improved in the Diabetes PDC score. All sites maintained a 5-Star score for RASA PDC postintervention. An average increase of 2.36% was observed for Cholesterol PDC across all sites. Possible lag time between the intervention and score improvements may limit relatability of results. Conclusions: This is the first study to report a positive trend between technician involvement in CPS and improvement in industry standard adherence performance measures. Further research capturing a longer time frame may be beneficial.

UR - http://www.scopus.com/inward/record.url?scp=84994201383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994201383&partnerID=8YFLogxK

U2 - 10.1177/8755122516669379

DO - 10.1177/8755122516669379

M3 - Article

VL - 32

SP - 230

EP - 233

JO - Journal of Pharmacy Technology

JF - Journal of Pharmacy Technology

SN - 8755-1225

IS - 6

ER -